Overview

Skin Perfusion Pressure Testing Device Market is estimated to value over USD 72.1 million by 2027 end and register a CAGR of over 8.6% during the forecast period 2020 to 2027.

Many diabetic patients around the world develop gangrene which leads to limb amputation. This can be prevented by undergoing skin perfusion pressure (SPP) testing. It is a non-invasive test and is primarily suggested to patients suffering from peripheral arterial disease (PAD).

The rising prevalence of diabetes is an important factor contributing to the market growth. Growing activities in medical tourism, especially in Asian countries, is an integral factor liable for the market proliferation. The emphasis of manufacturers on developing advanced devices coupled with rising demand for advanced skin perfusion pressure testing devices can be credited for the market augmentation.

Although, in order to operate skin perfusion pressure testing devices, highly trained and skilled resources are required so as to obtain reproducible and accurate results. A dearth of such skilled resources, especially in developing countries, may hamper the use of these testing devices thus impeding market growth.

Amputation Procedures Are On a Rise Amongst Diabetic Patients:

As per the International Diabetes Federation (IDF), the global incidence of diabetes is predicted to soar from 285 million to over 435 million by the end of 2030. Looking at these market trends, it shows lucrative revenue opportunities for the market which are prominently used for monitoring the ischemic conditions of diabetic patients.

Ultrasound and Angiography technologies are standard procedures for diagnosing wound healing testing and PAD. These new techniques have distinctive advantages over conventional blood testing, ankle-brachial index (ABI) testing and other non-invasive techniques. Furthermore, diagnostic laboratories, the ready availability of various imaging techniques and more reliable test outcomes boost the rate of adoption of SSDs over others, thus aidingmarket growth significantly.

Major key market players are:

Vasamed Incorporated, Moor Instruments, Perimed AB, CorVascular Diagnostics, LLC, ELCAT, Promed Group Co., Ltd., Shenzhen Ricso Technology Co., Ltd., Shenzhen Bestman Instrument Co., ltd., Viasonix, Biomedix (Collaborative Care Diagnostics, LLC), Koven Technology, Inc., Newman Medical.

FutureWise Key Takeaways:

Multidisciplinary wound management has recently gained popularity owing to knowledge diversification afar from conventional medical practices. Therefore, TBI, SPP, ABI and other vascular tests are now a part of daily diagnostic for nutritionists, infectious disease specialists, endocrinologists, vascular specialists group thus aiding the market growth
The systems that are currently available for skin perfusion pressure testing are provisioned with advanced automatic inflation or deflation features, data management software and segmental calculation algorithm. These inbuilt SPP device features enable real-time reporting, data sharing and storage through EMR

Skin Perfusion Pressure Testing Device Market Segmentation:

By Product Type

Systems
Laser Doppler SPP System
Photo plethysmography System
Ultrsound System
Accessories and Consumables
Pressure Cuffs
Electrodes
Probes
Others

By Mode

Cart-based devices
Portable devices

By End User

Hospitals
Outpatient Centres
Diagnostics Centres
Clinics
Others

By Region

North America
Europe
Asia Pacific
Latin America
Rest of the World

Skin Perfusion Pressure Testing Device Market Video Sample:

Objectives of the Study:

To provide with an exhaustive analysis on the global market by product type, by end user and by region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Europe Asia Pacific, Latin America and the rest of the world
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com